Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein

Endocrinology

Volumn 141, Issue 3, 2000, Pages 1041-1049

  Murray, Ian ^a   Havel, Peter J ^b   Sniderman, Allan D ^a   Cianflone, Katherine ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; GLUCOSE; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; KNOCKOUT MOUSE; LIPID DIET; LIPID METABOLISM; LOW FAT DIET; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

EID: 0034463865     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.3.7364     Document Type: Article

References (74)

1. Acylation stimulating protein (ASP), an adipocyte autocrine: New directions
2. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue
3. Acylation stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line
4. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation stimulating protein
5. Specific binding of ASP to human fibroblasts and human adipocytes
6. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin
7. Signal transduction pathway of acylation stimulating protein: Involvement of protein kinase C
8. The effect of acylation stimulating protein (ASP) and insulin on the release of fatty acids from isolated human fat cells
9. Structure and function of C3a anaphylatoxin
10. The adipsin-acylation stimulating protein system in human adipocytes: Regulation of triacylglycerol synthesis
11. Regulation of alternative pathway activation and C3a production by adipose cells
12. Differentiation induced production of ASP in human adipocytes
13. Acute in vitro production of ASP in differentiated adipocytes
14. Chylomicron specific enhancement of acylation stimulating protein (ASP) and precursor protein C3 production in differentiated human adipocytes
15. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period
16. Response of plasma ASP to a prolonged fast
17. Plasma ASP, adipsin, and lipids in non-obese and obese populations
18. The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers
19. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein (ASP) in C57BL/6 mice
20. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extra-hepatic expression of C3 mRNA
21. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo
22. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance
23. Positional cloning of the mouse obese gene and its human homologue
24. High-fat meals reduce 24-h circulating leptin concentrations in women
25. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes
26. Mechanisms regulating leptin production: Implications for control of energy balance
27. Leptin selectively decreases visceral adiposity and enhances insulin action
28. Leptin impairs metabolic actions of insulin in isolated rat adipocytes
29. In vitro lipolytic effect of leptin on mouse adipocytes: Evidence for a possible autocrine/paracrine role of leptin
30. Diet-induced obese mice develop peripheral, but not central, resistance to leptin
31. Regulation of plasma leptin in mice: Incluence of age, high-fat diet, and fasting
32. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia
33. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia
34. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes
35. Hypertriglyceridemia as a result of human Apo CIII gene expression in transgenic mice
36. Disruption of cholesterol 7 alpha-hydroxylase gene in mice
37. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital lipodystrophy
38. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action
39. Inheritance of plasma cholesterol levels in mice
40. 1 mice
41. Effect of age, sex, and sites on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet
42. Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia
43. Fat emulsion catabolism in vitro and in vivo-sex related differences
44. Clearance of triglycerides from the circulation and its relationship to serum lipoproteins: Influence of age and sex
45. Lipoprotein lipase expression exclusively in the liver. A mouse model for metabolism in the neonatal period and during cachexia
46. Overexpression of GLUT4 selectively in adipose tissue in transgenic mice: Implications for nutrient partitioning
47. Changes in lipid metabolism in diet-induced obesity
48. The adipocyte, fatty add trapping and atherogenesis
49. Lipoprotein lipase and the disposition of dietary fatty acids
50. 3-adrenoceptor in the regulation of body composition
51. Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes
52. Lepfin expression from adipose tissue in obese humans: Depot-specific regulation by Insulin and dexamethasone
53. Genetically lean mice result from targeted disruption of the RII-β subunit protein kinase A
54. 1-adrenergic receptor in adipose tissue are resistant to obesity
55. Regulation of fat and muscle development by transforming growth factor α in transgenic mice and cultured cells
56. Troglitazone action is independent of adipose tissue
57. Life without white fat: A transgenic mouse
58. Dietary composition, substrate balances and body fat in subjects with a predisposition to obesity
59. Modification of glucose tolerance and insulin-mediated glucose and non-esterified fatty acids utilization in morbid obese patients after a surgically induced massive weight loss
60. Residual abnormalities of insulin secretion and sensitivity after weight loss by obese women
61. Significant changes in blood pressure, glucose and lipids with gastric bypass surgery
62. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women
63. Effects of fasting, refeeding, and dietary fat restriction on plasma leptin levels
64. Complement C3 deficiency: Human, animal and experimental models
65. Genetic deficiency of acylation stimulating protein (ASP/C3asesArg) does not cause hyperapobetalipoproteinemia in mice
66. The complement abnormalities of lipodystrophy
67. Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): Clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies
68. C3 nephritic factor and SLE: Report of four cases and review of the literature
69. Partial lipodystrophy and familial C3 deficiency
70. Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities
71. Partial and total lipodystrophy: Changes in circulating sugar, non-esterified fatty acids, insulin and growth hormone following administration of glucose and insulin
72. Partial lipodystrophy with insulin resistant diabetes and hyperlipidemia (Dunnigan syndrome)
73. Metabolic studies of the third component of complement and the glycine-rich β glycoprotein in patients with hypocomplementemia
74. Two types of C3 nephritic factor: Properdin-dependent C3NeF and properdin-independent C3NeF